Diebold Nixdorf, Incorporated Stock Price and Value Analysis

Should you buy Diebold Nixdorf, Incorporated stock? (NYSE:DBD). Let's see how it does in our automated value investing analysis system.

DBD Free Cash Flow Trend

Free Cash Flow trendline for DBD
Free Cash Flow trendline for Diebold Nixdorf, Incorporated

Hmm, we can't give any reliable projection for Diebold Nixdorf, Incorporated's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the DBD Numbers

DBD Price
(Diebold Nixdorf, Incorporated stock price per share)
[?] PE Ratio versus Sector 57% higher than other Technology stocks
[?] PE Ratio versus Industry 96% higher than other Software - Application stocks
[?] Cash Yield 6.86%
[?] Free Cash Flow Jitter 395%

Is Diebold Nixdorf, Incorporated Stock on Sale?

Based on our analysis, we believe that you should not buy Diebold Nixdorf, Incorporated right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy DBD Stock?

Does Diebold Nixdorf, Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.